Read our Empower review to compare features, pricing, pros and cons. Learn if this free budgeting app fits your financial ...
Even after numerous FDA warnings, the agency hasn’t stopped Empower Pharmacy from producing drugs at a scale rarely — if ever ...
Empower and Milliman, Inc. today announced they have entered into a definitive agreement for Empower to acquire Milliman’s retirement administration business. The acquisition will add significant ...
Empower has agreed to buy Milliman's retirement administration business for $340 million, in a transaction that would add more than 1.5 million plan participants and roughly $130 billion in assets ...
Compounding pharmacies don't have to disclose reports of patient harm to the FDA. Nor do they have to abide by the stringent ...
Empower is a powerful and free financial analysis tool that helps users monitor net worth, track investment performance and ...
New research finds 79% of retirement plan participants believe all investors should have access to the same investment products as institutional investors 73% of plan participants agree that having ...
Much of the discussion in the U.S. nowadays revolves around how difficult it is to build a nest egg. Due to inflation, economic uncertainty, and other factors, many soon-to-be-retirees worry about not ...
GREENWOOD VILLAGE, Colo., November 06, 2025--(BUSINESS WIRE)--Empower today announced after-tax base earnings of $317 million for the third quarter of 2025, a 10% increase from the same period in 2024 ...
Empower’s push into personal wealth advisement has been gaining traction, with the division reporting 29% growth in average assets under administration to $86 billion in 2024 in part from “capturing ...
WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results